In a dextran sodium sulfate-induced acute colitis model, genetic deletion or pharmacological inhibition of Gal-3 significantly attenuated colitis severity, reduced production of pro-inflammatory cytokines (including IL-1β and tumor necrosis factor alpha [TNF-α]) and suppressed NLRP3 inflammasome activation [42]. This evidence concerns the gene TNF and colitis.